Weekly Insights & Analysis
Healthcare Private Placement and M&A Transactions Review Week Ending Feb 4, 2024
Strategy | Financing Transactions Private Placement / Financing Transactions Cellanome: The company raised $150 million of Series B venture funding from Premji Invest (US) and undisclosed investors on January 29, 2024, putting the company's pre-money valuation at $375...
Technology Private Placement and M&A Transactions Review Week Ending Jan 28, 2024
Strategy | Financing Transactions Private Placement / Financing Transactions ElevenLabs: The company raised $80 million of Series B venture funding in a deal led by Andreessen Horowitz, Nat Friedman and Daniel Gross on January 22, 2024, putting the company's pre-money...
Consumer Private Placement and M&A Transactions Review Week Ending Jan 28, 2024
Strategy | Financing Transactions Private Placement / Financing Transactions Ohalo Genetics: The company raised $40 million of venture funding from undisclosed investors on January 25, 2024. The company is a developer of a plant genetic technology. Protealis: The...
Healthcare Private Placement and M&A Transactions Review Week Ending Jan 28, 2024
Strategy | Financing Transactions Private Placement / Financing Transactions Synnovation Therapeutics: The company raised $102 million of Series A venture funding in a deal led by Third Rock Ventures on January 24, 2024, putting the company's pre-money valuation at...
Consumer Private Placement and M&A Transactions Review Week Ending Jan 21, 2024
Strategy | Financing Transactions Private Placement / Financing Transactions Bloom Nutrition: The company received $90 million of development capital from Nutrabolt, Amberstone and Mr. Clayton Christopher on January 17, 2024. The company is a producer and seller of...
A weekly digest of strategy and finance perspectives in charts, together with a review of M&A and private placement transactions by industry sector.